Morpholine derivatives for use as dopamine agonists in the treatment of I.a. sexual dysfunction

Details for Australian Patent Application No. 2003302878 (hide)

Owner Pfizer Inc.

Inventors Allerton, Charlotte Moira Norfor; Baxter, Andrew Douglas; Wong, Stephen Kwok-Fung; Cook, Andrew Simon; Hepworth, David

Agent Allens Arthur Robinson

Pub. Number AU-B-2003302878

PCT Number PCT/IB2003/0056

PCT Pub. Number WO2004/052372

Priority 0228787.8 10.12.02 GB; 0308460.5 11.04.03 GB; 0313606.6 12.06.03 GB

Filing date 2 December 2003

Wipo publication date 30 June 2004

Acceptance publication date 23 April 2009

International Classifications

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

C07D 265/30 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

29 July 2004 Complete Application Filed

  Priority application(s): 0228787.8 10.12.02 GB; 0308460.5 11.04.03 GB; 0313606.6 12.06.03 GB

5 August 2004 Application Open to Public Inspection

  Published as AU-B-2003302878

23 April 2009 Application Accepted

  Published as AU-B-2003302878

20 August 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003302879-A WEARABLE DEVICE FOR BIOELECTRICAL INTERACTION WITH MOTION ARTIFACT CORRECTION MEANS

2003302877-X-RAY SYSTEM